Related Experiment Video
Updated: Jul 5, 2026
08:35
Electrotaxis Studies of Lung Cancer Cells using a Multichannel Dual-electric-field Microfluidic Chip
Published on: December 29, 2015
9.2K
ECM-free lung tumoroids generated by an air-stretchable microfluidic chip.
Talha Chauhdari1, Jilei Su1, Jiabao Lv1
1College of Life Sciences, University of Chinese Academy of Sciences, No.1 Yanqihu East Rd, Huairou District, 101408 Beijing China.
In Vitro Models
|March 6, 2026
Summary
A novel microfluidic lung tumoroid model mimics the tumor microenvironment, showing mechanical forces increase drug resistance. This platform aids lung cancer research and drug screening for better therapies.
Area of Science:
- Biomedical Engineering
- Oncology
- 3D Cell Culture
Background:
- Lung cancer is a leading cause of mortality, necessitating advanced therapeutic strategies and in vitro models.
- Existing in vitro models struggle to replicate the complex in vivo tumor microenvironment (TME) and drug responses.
- Three-dimensional (3D) in vitro models like organoids and tumoroids show promise but often rely on costly extracellular matrix (ECM).
Purpose of the Study:
- To develop a cost-effective, physiologically relevant 3D lung tumoroid model using microfluidics.
- To investigate the impact of mechanical cues (alveolar stretching and air-liquid interface) on lung tumoroid behavior and drug response.
- To compare tumoroid formation capacity across different lung cancer cell lines.
Main Methods:
- A microfluidic chip was engineered to create a lung tumoroid model incorporating lung cancer, endothelial, and fibroblast cells.
- The model integrated alveolar stretching and air-liquid interface (ALI) conditions without exogenous ECM.
- Tumoroid formation was assessed across three lung cancer cell lines, and drug sensitivity was evaluated under static vs. dynamic conditions.
Main Results:
- The microfluidic chip successfully generated lung tumoroids capable of mimicking alveolar stretching and ALI.
- NCI-H1299 cells, characterized by low E-cadherin expression, failed to form tumoroids, indicating cell-specific formation capacity.
- Tumoroids exposed to ALI and cyclic stretch demonstrated increased drug resistance compared to static controls, highlighting mechanical cue importance.
Conclusions:
- The microfluidic chip-based lung tumoroid model provides a more physiologically relevant platform for studying lung cancer biology.
- Mechanical forces significantly modulate tumor behavior and drug resistance, crucial factors for in vitro model development.
- This advanced model can accelerate lung cancer drug screening and the development of novel therapeutic strategies.
